Growth Metrics

Oruka Therapeutics (ORKA) Leases (2019 - 2026)

Oruka Therapeutics' quarterly Leases came in at $1.7 million in Q1 2026, up 107.25% year-on-year from $814000.0 in Q1 2025, and down 7.81% quarter-over-quarter from $1.8 million in Q4 2025.

Oruka Therapeutics has reported Leases for 8 years, with the latest figure at $1.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Leases rose 107.25% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (up 107.25% YoY), and the FY2025 full-year result was $1.8 million, up 108.9% from the prior year.
  • Leases for Q1 2026 stood at $1.7 million, down from $1.8 million in the prior quarter.
  • The five-year high for Leases was $2.1 million in Q2 2025, with the low at $8000.0 in Q2 2024.
  • Average Leases over 5 years is $756176.5, with a median of $391000.0 recorded in 2022.
  • Year-over-year, Leases tumbled 97.27% in 2024 and soared 25850.0% in 2025.
  • Tracing ORKA's Leases over 5 years: stood at $343000.0 in 2022, then declined by 27.99% to $247000.0 in 2023, then soared by 254.66% to $876000.0 in 2024, then soared by 108.9% to $1.8 million in 2025, then declined by 7.81% to $1.7 million in 2026.
  • The last three Leases figures came in at $1.7 million (Q1 2026), $1.8 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 61,822.50
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 189.30 Mn
10 Oruka Therapeutics 3.04 Bn 2.65 Bn - 1.69 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.69 Mn
Dec 31, 2025 1.83 Mn
Sep 30, 2025 1.97 Mn
Jun 30, 2025 2.08 Mn
Mar 31, 2025 814,000.00
Dec 31, 2024 876,000.00
Sep 30, 2024 938,000.00
Jun 30, 2024 8,000.00
Mar 31, 2024 17,000.00
Dec 31, 2023 247,000.00
Sep 30, 2023 267,000.00
Jun 30, 2023 293,000.00
Mar 31, 2023 318,000.00
Dec 31, 2022 343,000.00
Sep 30, 2022 367,000.00
Jun 30, 2022 391,000.00
Mar 31, 2022 414,000.00
Dec 31, 2021 437,000.00
Sep 30, 2021 460,000.00
Jun 30, 2021 482,000.00
Mar 31, 2021 414,000.00
Dec 31, 2020 428,000.00
Jun 30, 2020 24,000.00
Mar 31, 2020 49,000.00
Dec 31, 2019 22,000.00
Sep 30, 2019 11,000.00
Jun 30, 2019 28,000.00
Mar 31, 2019 44,000.00